Henry Kao

468 total citations
13 papers, 319 citations indexed

About

Henry Kao is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Henry Kao has authored 13 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Henry Kao's work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Henry Kao is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Henry Kao collaborates with scholars based in United States, Switzerland and Germany. Henry Kao's co-authors include Olivera J. Finn, Paul M. Allen, Theresa L. Whiteside, Jeffrey Shabanowitz, Sydney Finkelstein, Jarrod A. Marto, Thomas K. Hoffmann, Donald F. Hunt, James A. Burke and Karl G. Csaky and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Cancer Research.

In The Last Decade

Henry Kao

13 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Kao United States 8 147 122 100 97 89 13 319
María José Blanco‐Teijeiro Spain 9 62 0.4× 72 0.6× 47 0.5× 198 2.0× 92 1.0× 24 271
Joshua S. Hardin United States 7 45 0.3× 121 1.0× 123 1.2× 140 1.4× 175 2.0× 19 437
William Glasson Australia 10 131 0.9× 63 0.5× 136 1.4× 324 3.3× 170 1.9× 24 432
Zita F. H. M. Boonman Netherlands 9 305 2.1× 38 0.3× 122 1.2× 98 1.0× 75 0.8× 10 383
Adeel H. Shaikh United States 6 65 0.4× 78 0.6× 107 1.1× 289 3.0× 121 1.4× 11 317
Natasha M. van Poppelen Netherlands 10 84 0.6× 29 0.2× 110 1.1× 204 2.1× 121 1.4× 12 269
L A Lee United States 7 148 1.0× 81 0.7× 35 0.3× 17 0.2× 80 0.9× 7 338
Sandra García‐Mulero Spain 10 114 0.8× 18 0.1× 110 1.1× 74 0.8× 127 1.4× 19 304
Kyra N. Smit Netherlands 10 140 1.0× 45 0.4× 108 1.1× 306 3.2× 240 2.7× 14 402
Olivier Loria France 9 55 0.4× 41 0.3× 53 0.5× 167 1.7× 112 1.3× 26 349

Countries citing papers authored by Henry Kao

Since Specialization
Citations

This map shows the geographic impact of Henry Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Kao more than expected).

Fields of papers citing papers by Henry Kao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Kao. The network helps show where Henry Kao may publish in the future.

Co-authorship network of co-authors of Henry Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Kao. A scholar is included among the top collaborators of Henry Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Kao. Henry Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Herzig, Petra, Markus Germann, Petra Schwalie, et al.. (2025). PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer. Science Translational Medicine. 17(816). eadr3718–eadr3718. 1 indexed citations
2.
Cannarile, Michael A., Vaios Karanikas, Bernhard Reis, et al.. (2023). Facts and Hopes on Biomarkers for Successful Early Clinical Immunotherapy Trials: Innovative Patient Enrichment Strategies. Clinical Cancer Research. 30(8). 1448–1456. 1 indexed citations
3.
Junker, Fabian, Uwe Wessels, Stefan Seeber, et al.. (2021). A human receptor occupancy assay to measure anti‐PD‐1 binding in patients with prior anti‐PD‐1. Cytometry Part A. 99(8). 832–843. 11 indexed citations
4.
Ferris, Robert L., George R. Blumenschein, Kevin J. Harrington, et al.. (2017). Abstract CT022: Evaluation of oral microbiome profiling as a response biomarker in squamous cell carcinoma of the head and neck: Analyses from CheckMate 141. Cancer Research. 77(13_Supplement). CT022–CT022. 21 indexed citations
5.
Masters, Gregg, et al.. (2014). Abstract 5016: Antitumor activity of anti-PD-1 in combination with tyrosine kinase inhibitors in a preclinical renal cell carcinoma model. Cancer Research. 74(19_Supplement). 5016–5016. 4 indexed citations
6.
Devine, Emily Beth, Lingtak‐Neander Chan, Joseph B. Babigumira, et al.. (2010). Postoperative Acquired Coagulopathy: A Pilot Study to Determine the Impact on Clinical and Economic Outcomes. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(10). 994–1003. 7 indexed citations
7.
Lee, Susan S., Corine Ghosn, Zhi‐Ling Yu, et al.. (2010). Vitreous VEGF Clearance Is Increased after Vitrectomy. Investigative Ophthalmology & Visual Science. 51(4). 2135–2135. 96 indexed citations
8.
Robinson, Michael R., Corine Ghosn, Leandro Cabral Zacharias, et al.. (2009). Vitreous VEGF Clearance is Increased Following Vitrectomy. 50(13). 3567–3567. 2 indexed citations
9.
Morley, Sharon Celeste, K. Scott Weber, Henry Kao, & Paul M. Allen. (2008). Protein Kinase C-θ Is Required for Efficient Positive Selection. The Journal of Immunology. 181(7). 4696–4708. 24 indexed citations
10.
Kao, Henry, Joseph Lin, Dan R. Littman, Andréy S. Shaw, & Paul M. Allen. (2008). Regulated Movement of CD4 In and Out of the Immunological Synapse. The Journal of Immunology. 181(12). 8248–8257. 9 indexed citations
11.
Kao, Henry & Paul M. Allen. (2005). An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II–restricted T cells in the absence of CD4. The Journal of Experimental Medicine. 201(1). 149–158. 16 indexed citations
12.
Kao, Henry, Jarrod A. Marto, Thomas K. Hoffmann, et al.. (2001). Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells. The Journal of Experimental Medicine. 194(9). 1313–1324. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026